REFERENCES
- Flecter C, Pearson C, Choi SC, et al. In vitro compari-son of antiplatelet effects of beta-lactam antibiotics. J Lab Clin Med 1986; 108: 217–223.
- Andrassy K, Koderisch J, Fritz S, Bechtold H, Sonntag H. Alteration of hemostasis associated with cefoperazone treatment. Infection 1986; 14: 27–31.
- Ziemen M, Shan PM, Henkel-Bussmann M, Breddin HK. Hamostaseologische parameter unter dem Einfluss von Imipenem/Cilastatin. Infection 1986; 14 (Suppl 2): S138–S142.
- Nakano T, Terawaki A, Arita H. Influence of beta-lac-tam antibiotics on platelets. II. In vitro effects of some beta-lactam antibiotics on the biochemical responses of rat platelets. J Pharmacobiodyn 1987; 10: 408–420.
- Burroughs SF, Johnson GJ. Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibi-tion of the platelet activation in vitro and in vivo after pro-longed exposure to penicillin. Blood 1990; 75: 1473–1480.
- Cazzola M, Santangelo G, Martucci P, Caputi M. An in vitro study of the possible interaction between human platelets and cephalosporins. Int J Clin Pharm Res 1991; 11: 7–10.
- Nubile G, Saccone A, Di Gregorio M, Rossi M, Tresca E. L'azione degli aminoglicosidi sulla aggregazione piastinica in vitro. Boll Soc Ital Biol Sper 1985; 61: 357–363.
- Tysnes OB, Steen VM, Holmsen H. Neomycin inhibits platelet functions and inositol phospholipid metabolism upon stimulation with thrombin, but not with ionomycin or 12-0-tetradecanoyl-phorbol 13-acetate. Eur J Biochem 1988; 177: 219–223.
- Moake UL, Cimo PL, Peterson DM, Roper P, Natelson EA. Inhibition of ristocetin-induced platelet aggregation by vancomycin. Blood 1977; 50: 397–406.
- Porta M, Ricchetti I. A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin). Int J Clin Pharmacol Ther Toxicol 1986; 24: 661–664.
- Agnelli G, Guerciolini R, GrasseIli S, Menichetti F, Pauluzzi S, Nenci GG, Del Favero A. Effects of the monobactam antibiotic aztreonam on platelet function and blood coagulation . Chemotherapy 1987; 33: 9–14.
- Agnelli G, Longhetti M, Guerciolini R et al. Effects of the new glycopeptide antibiotic teicoplanin on platelet and blood coagulation. Antimicrob Agents Chemother 1987; 31: 1609–1612.
- Cazzola M, Santangelo G, Paizis G, Matera C, Rossi F. Effects of cefonicid on platelet aggregation. Drugs Exptl Clin Res 1991; 17: 1609–1612.
- Cazzola M, Matera MG, Gusmitta A, Rossi F. Effect of flomoxef on human platelet aggregation. Eur J Clin Pharmacol 1991; 41: 503–504.
- Rossi F, Santangelo G, Loffreda A, Angrisani M, Matera C, Cazzola M. Effects of teicoplanin on human platelet aggregation in vitro and in vivo. J Chemother 1992; 4: 159–162.
- Reuter HD, Thiele S. Untersuchungen Zum Einfluss von Ciprofloxacin auf die durch Epinefrin un kollagen induzierte thrombozytenaaggregation in vitro. Arzneimit-telforschung 1986; 36: 1144–1147.
- Reuter HD, Thiele S, Honing R. Zum einfluss von ciprofloxacin auf die durch epinephrin und kollagen induzierte thrombozytenaaggregation in vitro bei dialysepa-tienten. Arzneimittelforschung 1988; 38: 727–729.
- Sirtori C. Farmacologia clinica dei nuovi fluorochi-noloni. In: Sirtori CR, Garaci E, ed, I Fluorochinoloni sis-temici. Napoli: Martinucci, 1990: 47-58.
- Bassetti D. Chemioterapici antiinfettivi e loro impiego razionale. V ed. Milano: Intramed, 1991: 173–189.
- Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–939.
- Webberley JM, Andrews JM, Ashby JP, McLeod A, Wise R. Pharmacokinetics and tissue penetration of orally administered pefloxacin. Eur J Clin Microbiol 1987; 6: 521–524.
- Saba HI. Endotoxin-mediated inhibition of human platelet aggregation. Thromb Res 1984; 34: 19–33.
- Sunakawa K. Effects of antibiotics on platelet aggrega-tion. Drugs 1988; 35 (Suppl 2): 205–207.
- Kaplan SL, Courtney JT, Kenai Kaf. Effect of Haemophilus inlluenzae infection and moxalactam on platelet function in children. Antimicrob Agents Chemother 1987; 31: 467–469.
- Cardey J, Silavain C, Bouquet S, Breux JP, Becq-Giraudon B, Fourtillan JP, Beauchant M. Oral pharmacoki-netics and ascitic fluid penetration of pefloxacin in cirrhosis. Eur J Clin Pharmacol 1987; 33: 469–472.